The race is under way to make faster, cheaper and better GLP-1 drugs that will go beyond reducing obesity levels to treating ...

Anecdotal reports suggest drugs like Ozempic may curb not just appetite but also impulsive or addictive behaviour, hinting at ...

The recent uptick and rise in popularity of GLP-1 drugs for addressing weight loss and obesity has led to an increase in U.S. litigation ...

There’s no question about the popularity of GLP-1 weight loss drugs like Ozempic and Wegovy, but some doctors are worried the ...

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...

GLP-1 agonists may lead to increased nausea and vomiting in the early postoperative period after total hip arthroplasty, ...

The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...

Researchers identified how a brain circuit involving dopamine and GLP-1 receptor impact palatability and hedonic eating.

More Type 1 Diabetics Are Obese, Taking GLP-1 Drugs By Dennis Thompson HealthDay ... on the effectiveness and safety of GLP-1 receptor agonists in people with type 1 diabetes, to inform clear ...

Spending growth for simple medications used to treat common health problems is outstripping spending growth for pricey medications used to treat complex and chronic conditions, according to a new ...

This Texas-based company thinks so. ChipMonk Baking has been in the game of making healthier cookies since long before GLP-1 agonist weight-loss drugs like Ozempic and Wegovy took the U.S. by storm.

Employers, including Express Scripts parent company Cigna, seek to manage GLP-1 costs through programs administered by the ...